India Director Of Health Services Cited For Overpriced AZ Drug
This article was originally published in PharmAsia News
Executive Summary
Indian authorities are investigating a possible scandal involving health officials negotiating with a supplier of an AstraZeneca Pharma India drug to supply the government at a higher-than-normal price.